Tag:

FTC

Latest Headlines

Latest Headlines

FTC privacy proposal could serve as model for future HIPAA updates

Consumers must have an up-front option regarding the shared use of their personal information, the Federal Trade Commission argues in a report published this week. While the privacy framework

Government cracks down on misleading medical apps

In its first enforcement action in the mobile health market, the Federal Trade Commission has forced two app companies to stop making health claims for their smartphone apps. The two apps, AcnePwner

Government cracks down on misleading medical apps

In its first enforcement action in the mobile health market, the Federal Trade Commission has forced two app companies to stop making health claims for their smartphone apps. The two apps, AcnePwner

Do ACOs violate antitrust laws?

Despite growing concerns about their legality, most accountable care organizations (ACOs) will not violate antitrust laws, said Gail Kursh, JD, deputy chief of the legal policy section of the

Georgia hospital deal scrutinized as 'monopolistic' by FTC

The Federal Trade Commission board voted unanimously Wednesday to challenge a pending deal for Albany, Ga.-based Phoebe Putney Health System to acquire Palmyra Park Hospital, also in Albany, from

FTC, DoJ battling over ACO jurisdiction

A "turf battle" is brewing between the U.S. Justice Department and the Federal Trade Commission over which agency will have purview of accountable care organizations, the Wall Street Journal reports.

Court decision ends Red Flags dispute

A recent federal appeals court decision--which dismissed a suit focusing on the Federal Trade Commission's (FTC) so-called Red Flags Rule--"validates" its long-standing argument that physicians who

Court decision ends Red Flags Rule dispute, AMA says

A recent federal appeals court decision--which dismissed a suit focusing on the Federal Trade Commission's (FTC) so-called Red Flags Rule--"validates" its long-standing argument that physicians who

Supreme Court declines to hear 'pay-to-delay' pharma case

The federal government's decade-long quest to limit pharmaceutical manufacturers' actions to keep generic medications off the market for a specified time--through deals called "pay-to-delay"--ran

DoJ, FTC differ on antitrust rules for ACOs

The Justice Department and Federal Trade Commission are butting heads over which agency should get to enforce antitrust laws that affect the formation of accountable care organizations, the New York